Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Urinary Bladder Neoplasms 5Non-Muscle Invasive Bladder Neoplasms 4Urothelial Carcinoma of the Bladder 1Peritoneal Neoplasms 1Peritoneal Diseases 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Gemcitabine 6Mitomycin 4erdafitinib 3viscum album peptide 1pirarubicin 1hydroxycamptothecinum 1durvalumab 1Watchful Waiting 1Transurethral Resection of Bladder 1Magnetic Resonance Spectroscopy 1Injections 1Epirubicin 1Cystoscopy 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Mitomycin × 30 days × Clear all
NCT06211764 2026-06-05

SunRISe-5

Janssen Research & Development, LLC

Phase 3 Active not recruiting
272 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06919965 2026-06-05

MoonRISe-3

Janssen Research & Development, LLC

Phase 3 Recruiting
220 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT02106572 2026-05-22

TIM

Abnoba Gmbh

Phase 3 Terminated
174 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡